<DOC>
	<DOC>NCT01363999</DOC>
	<brief_summary>A single-center, crossover study to evaluate the pharmacokinetics of dalcetrapib and atorvastatin from prototype fixed dose combination formulations in healthy volunteers. Volunteers will receive a single dose of dalcetrapib with atorvastatin in each of four treatment periods.</brief_summary>
	<brief_title>A Formulation Screening Study of Dalcetrapib and Atorvastatin in Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Dalcetrapib</mesh_term>
	<criteria>Healthy volunteers, 18 to 55 years of age, inclusive Any concomitant disease or ongoing condition that in the investigator's opinion could interfere with the study or could pose an unacceptable risk to the patient Clinically significant abnormal laboratory values</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>